By contrast, up-regulated SIGLEC15 expression was associated with shorter OS in kidney renal clear cell carcinoma, pancreatic adenocarcinoma and Sarcoma, and with shorter RFS in SARC and PAAD (47). Here, SIGLEC15 is linked to sarcoma.